Why the study?
To analyze the immediate and medium-term results of aortic valve replacement using biological prosthesis in elderly patients.
What are the immediate and medium-term outcomes of aortic valve replacement with biological prosthesis in elderly patients?
What are the immediate and medium-term outcomes of aortic valve replacement with biological prosthesis in elderly patients?
Aortic valve replacement with biological prostheses in elderly patients provides excellent 5-year freedom from re-operation (97.1%), though overall 5-year survival is 63% due to age and comorbidities.
Answers are grounded in this paper and cite their sources.
Biological AVR yields high durability in elderly; leaves open survival drivers in this Level 3 cohort.
Objective. To analyze the immediate and medium-term results of prosthetics of the aortic valve (AV) using biological prosthesis in elderly patients. Material and methods. The study included 198 patients with AV pathology [85 men (42.9 %)/113 women (57.1 %)]. The median age was 70 [66–73] years. There were 175 (88.4 %) patients with sclerodegenerative AV, 5 (2.5 %) – with infectious endocarditis and 30 patients (15.2 %) had bicuspid AV. Results. The hospital mortality was 4.5 %. The causes of mortality were multiple organ failure syndrome, in 1 case – developed peritonitis. In 14 patients (7.1 %) there was a rhythm disturbance in the form of AF, in 9 (4.5 %) – a complete AV block, in connection with which a permanent pacemaker was implanted. Four patients (2 %) underwent resternotomy for bleeding. Two patients (1 %) underwent pericardiocentesis. 8 (4 %) patients developed a stroke. No wound complications were detected. In the long-term period, 31 patients died. The causes of mortality were the following: cardiovascular diseases – 13 patients, malignant neoplasms – 5 patients, gastrointestinal diseases – 2, urinary system disease – 1 patient, COVID-19 – 1 patient, unknown cause – 9 patients. Thus, the five-year survival rate after the surgery was 63 %, respectively. During the follow-up period, 2 patients (2.9 %) underwent repeated intervention on AV. Conclusions. The five-year freedom from re-operation was 97.1 %. The five-year survival rate was 63 % due to the presence of a history of severe concomitant pathology as well as the middle age of patients 70 years.
No takes yet. Share an insight, caveat, or question.
Kadyraliev et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: